An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin.

Trial Profile

An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 Nov 2013

At a glance

  • Drugs Exemestane (Primary)
  • Indications Early breast cancer
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Sep 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 18 Apr 2011 Planned End Date changed from 1 Aug 2015 to 1 Aug 2013, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top